🇺🇸 Lipiodol in United States

981 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 261 reports (26.61%)
  2. Product Use In Unapproved Indication — 260 reports (26.5%)
  3. Liver Abscess — 100 reports (10.19%)
  4. Product Use Issue — 81 reports (8.26%)
  5. Pyrexia — 66 reports (6.73%)
  6. Aspartate Aminotransferase Increased — 49 reports (4.99%)
  7. Pulmonary Embolism — 48 reports (4.89%)
  8. Alanine Aminotransferase Increased — 47 reports (4.79%)
  9. Cerebral Artery Embolism — 38 reports (3.87%)
  10. Cholecystitis Acute — 31 reports (3.16%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Lipiodol approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Lipiodol in United States?

Shanghai Zhongshan Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.